Contribute
Program › Viral protein annotation program
Statistics
UniProt release 2013_06 - May-29, 2013 contains a total of 540,261 reviewed entries, which includes 16,331 entries from 942 species of virus.
Human immunodeficiency virus type 1 (isolate HXB2) (HIV-1)
9 entries (Viralzone: Lentivirus)
| Evidence for the existence of protein | Percentage of entries |
|---|---|
| at protein level | 77.8% |
| at transcript level | N/A |
| inferred from homology | 22.2% |
| predicted | N/A |
| uncertain | N/A |
| Annotation categories | Entries with | Number of annotations | Coverage |
|---|---|---|---|
| PubMed citations | 9 | 129 unique | 100% |
| Alternative products | 3 | 6 | 33.3% |
| General annotation | 9 | 183 | 100% |
| Function | 9 | 30 | 100% |
| Catalytic activity | 1 | 4 | 11.1% |
| Subcellular location | 9 | 183 | 100% |
| Subunit / Interacts with host | 9 | - | 100% |
| Sequence annotation | 9 | 626 | 100% |
| Amino acid modifications | 8 | 64 | 88.9% |
| Mutagenesis | 6 | 71 | 66.7% |
| Cross-references | 9 | 537 | 100% |
| EMBL | 9 | 15 | 100% |
| InterPro | 9 | 39 | 100% |
| PDB | 4 | 176 | 44.4% |
| RefSeq | 7 | 7 | 77.8% |
100% of reviewed HIV-1 entries are annotated with at least one keyword.
100% of reviewed HIV-1 entries are annotated with at least one GO (Gene Ontology) term.
Influenza A virus (strain A/Puerto Rico/8/1934 H1N1)
12 entries (Viralzone: Influenzavirus A)
| Evidence for the existence of protein | Percentage of entries |
|---|---|
| at protein level | 75% |
| at transcript level | N/A |
| inferred from homology | 25% |
| predicted | N/A |
| uncertain | N/A |
| Annotation categories | Entries with | Number of annotations | Coverage |
|---|---|---|---|
| PubMed citations | 12 | 44 unique | 100% |
| Alternative products | 6 | 12 | 50% |
| General annotation | 12 | 93 | 100% |
| Function | 12 | 14 | 100% |
| Catalytic activity | 2 | 2 | 16.7% |
| Subcellular location | 10 | 93 | 83.3% |
| Subunit / Interacts with host | 10 | - | 83.3% |
| Sequence annotation | 11 | 311 | 91.7% |
| Amino acid modifications | 4 | 42 | 33.3% |
| Mutagenesis | 2 | 31 | 16.7% |
| Cross-references | 12 | 266 | 100% |
| EMBL | 12 | 56 | 100% |
| InterPro | 12 | 23 | 100% |
| PDB | 9 | 30 | 75% |
| RefSeq | 12 | 12 | 100% |
100% of reviewed Influenza A virus entries are annotated with at least one keyword.
100% of reviewed Influenza A virus entries are annotated with at least one GO (Gene Ontology) term.
Hepatitis B virus genotype C subtype ayr (HBV-C)
0 entries (Viralzone: Orthohepadnavirus)
| Evidence for the existence of protein | Percentage of entries |
|---|---|
| at protein level | N/A |
| at transcript level | N/A |
| inferred from homology | N/A |
| predicted | N/A |
| uncertain | N/A |
| Annotation categories | Entries with | Number of annotations | Coverage |
|---|---|---|---|
| PubMed citations | 0 | 0 unique | N/A |
| Alternative products | 0 | 0 | N/A |
| General annotation | 0 | 0 | N/A |
| Function | 0 | 0 | N/A |
| Catalytic activity | 0 | 0 | N/A |
| Subcellular location | 0 | 0 | N/A |
| Subunit / Interacts with host | 0 | - | N/A |
| Sequence annotation | 0 | 0 | N/A |
| Amino acid modifications | 0 | 0 | N/A |
| Mutagenesis | 0 | 0 | N/A |
| Cross-references | 0 | 0 | N/A |
| EMBL | 0 | 0 | N/A |
| InterPro | 0 | 0 | N/A |
| PDB | 0 | 0 | N/A |
| RefSeq | 0 | 0 | N/A |
N/A of reviewed HBV-C entries are annotated with at least one keyword.
N/A of reviewed HBV-C entries are annotated with at least one GO (Gene Ontology) term.
Hepatitis C virus genotype 1a (isolate H) (HCV)
2 entries (Viralzone: Hepacivirus)
| Evidence for the existence of protein | Percentage of entries |
|---|---|
| at protein level | 100% |
| at transcript level | N/A |
| inferred from homology | N/A |
| predicted | N/A |
| uncertain | N/A |
| Annotation categories | Entries with | Number of annotations | Coverage |
|---|---|---|---|
| PubMed citations | 2 | 48 unique | 100% |
| Alternative products | 2 | 4 | 100% |
| General annotation | 2 | 78 | 100% |
| Function | 1 | 8 | 50% |
| Catalytic activity | 1 | 4 | 50% |
| Subcellular location | 2 | 78 | 100% |
| Subunit / Interacts with host | 1 | - | 50% |
| Sequence annotation | 2 | 321 | 100% |
| Amino acid modifications | 1 | 27 | 50% |
| Mutagenesis | 1 | 9 | 50% |
| Cross-references | 2 | 120 | 100% |
| EMBL | 2 | 7 | 100% |
| InterPro | 2 | 20 | 100% |
| PDB | 1 | 29 | 50% |
| RefSeq | 0 | 0 | N/A |
100% of reviewed HCV entries are annotated with at least one keyword.
100% of reviewed HCV entries are annotated with at least one GO (Gene Ontology) term.
Measles virus (strain Ichinose-B95a) (MeV)
8 entries (Viralzone: Morbilivirus)
| Evidence for the existence of protein | Percentage of entries |
|---|---|
| at protein level | 25% |
| at transcript level | N/A |
| inferred from homology | 75% |
| predicted | N/A |
| uncertain | N/A |
| Annotation categories | Entries with | Number of annotations | Coverage |
|---|---|---|---|
| PubMed citations | 8 | 8 unique | 100% |
| Alternative products | 0 | 0 | N/A |
| General annotation | 8 | 42 | 100% |
| Function | 7 | 7 | 87.5% |
| Catalytic activity | 1 | 2 | 12.5% |
| Subcellular location | 6 | 42 | 75% |
| Subunit / Interacts with host | 3 | - | 37.5% |
| Sequence annotation | 6 | 84 | 75% |
| Amino acid modifications | 2 | 14 | 25% |
| Mutagenesis | 0 | 0 | N/A |
| Cross-references | 8 | 71 | 100% |
| EMBL | 8 | 8 | 100% |
| InterPro | 8 | 14 | 100% |
| PDB | 1 | 1 | 12.5% |
| RefSeq | 7 | 7 | 87.5% |
100% of reviewed Measles virus entries are annotated with at least one keyword.
87.5% of reviewed Measles virus entries are annotated with at least one GO (Gene Ontology) term.
Dengue virus type 1 (strain Nauru/West Pac/1974) (DENV-1)
1 entries (Viralzone: Flavivirus)
| Evidence for the existence of protein | Percentage of entries |
|---|---|
| at protein level | 100% |
| at transcript level | N/A |
| inferred from homology | N/A |
| predicted | N/A |
| uncertain | N/A |
| Annotation categories | Entries with | Number of annotations | Coverage |
|---|---|---|---|
| PubMed citations | 1 | 6 unique | 100% |
| Alternative products | 0 | 0 | N/A |
| General annotation | 1 | 60 | 100% |
| Function | 1 | 11 | 100% |
| Catalytic activity | 1 | 6 | 100% |
| Subcellular location | 1 | 60 | 100% |
| Subunit / Interacts with host | 1 | - | 100% |
| Sequence annotation | 1 | 181 | 100% |
| Amino acid modifications | 1 | 13 | 100% |
| Mutagenesis | 0 | 0 | N/A |
| Cross-references | 1 | 78 | 100% |
| EMBL | 1 | 4 | 100% |
| InterPro | 1 | 26 | 100% |
| PDB | 1 | 5 | 100% |
| RefSeq | 1 | 1 | 100% |
100% of reviewed DENV-1 entries are annotated with at least one keyword.
100% of reviewed DENV-1 entries are annotated with at least one GO (Gene Ontology) term.
Zaire ebolavirus (strain Mayinga-76) (ZEBOV)
9 entries (Viralzone: Ebolavirus)
| Evidence for the existence of protein | Percentage of entries |
|---|---|
| at protein level | 77.8% |
| at transcript level | 11.1% |
| inferred from homology | 11.1% |
| predicted | N/A |
| uncertain | N/A |
| Annotation categories | Entries with | Number of annotations | Coverage |
|---|---|---|---|
| PubMed citations | 9 | 72 unique | 100% |
| Alternative products | 0 | 0 | N/A |
| General annotation | 9 | 90 | 100% |
| Function | 8 | 12 | 88.9% |
| Catalytic activity | 1 | 2 | 11.1% |
| Subcellular location | 9 | 90 | 100% |
| Subunit / Interacts with host | 4 | - | 44.4% |
| Sequence annotation | 9 | 206 | 100% |
| Amino acid modifications | 3 | 43 | 33.3% |
| Mutagenesis | 5 | 82 | 55.6% |
| Cross-references | 9 | 147 | 100% |
| EMBL | 9 | 49 | 100% |
| InterPro | 9 | 14 | 100% |
| PDB | 3 | 13 | 33.3% |
| RefSeq | 9 | 9 | 100% |
100% of reviewed Zaire ebolavirus entries are annotated with at least one keyword.
100% of reviewed Zaire ebolavirus entries are annotated with at least one GO (Gene Ontology) term.
Human herpesvirus 1 (strain 17) (HHV-1)
73 entries (Viralzone: Simplexvirus)
| Evidence for the existence of protein | Percentage of entries |
|---|---|
| at protein level | 75.3% |
| at transcript level | N/A |
| inferred from homology | 24.7% |
| predicted | N/A |
| uncertain | N/A |
| Annotation categories | Entries with | Number of annotations | Coverage |
|---|---|---|---|
| PubMed citations | 73 | 250 unique | 100% |
| Alternative products | 4 | 8 | 5.5% |
| General annotation | 73 | 476 | 100% |
| Function | 63 | 69 | 86.3% |
| Catalytic activity | 10 | 11 | 13.7% |
| Subcellular location | 67 | 476 | 91.8% |
| Subunit / Interacts with host | 20 | - | 27.4% |
| Sequence annotation | 62 | 921 | 84.9% |
| Amino acid modifications | 20 | 76 | 27.4% |
| Mutagenesis | 9 | 23 | 12.3% |
| Cross-references | 73 | 1,019 | 100% |
| EMBL | 73 | 257 | 100% |
| InterPro | 72 | 107 | 98.6% |
| PDB | 11 | 47 | 15.1% |
| RefSeq | 73 | 77 | 100% |
100% of reviewed Human herpesvirus 1 entries are annotated with at least one keyword.
97.3% of reviewed Human herpesvirus 1 entries are annotated with at least one GO (Gene Ontology) term.
Rotavirus A (isolate Monkey/South Africa/SA11-H96/1958) (RV-A)
12 entries (Viralzone: Rotavirus A)
| Evidence for the existence of protein | Percentage of entries |
|---|---|
| at protein level | 41.7% |
| at transcript level | N/A |
| inferred from homology | 58.3% |
| predicted | N/A |
| uncertain | N/A |
| Annotation categories | Entries with | Number of annotations | Coverage |
|---|---|---|---|
| PubMed citations | 12 | 15 unique | 100% |
| Alternative products | 1 | 2 | 8.3% |
| General annotation | 12 | 83 | 100% |
| Function | 11 | 14 | 91.7% |
| Catalytic activity | 2 | 3 | 16.7% |
| Subcellular location | 11 | 83 | 91.7% |
| Subunit / Interacts with host | 5 | - | 41.7% |
| Sequence annotation | 11 | 75 | 91.7% |
| Amino acid modifications | 4 | 17 | 33.3% |
| Mutagenesis | 2 | 11 | 16.7% |
| Cross-references | 12 | 97 | 100% |
| EMBL | 12 | 12 | 100% |
| InterPro | 12 | 20 | 100% |
| PDB | 0 | 0 | N/A |
| RefSeq | 12 | 12 | 100% |
100% of reviewed Rotavirus A entries are annotated with at least one keyword.
100% of reviewed Rotavirus A entries are annotated with at least one GO (Gene Ontology) term.
Human papillomavirus type 32
6 entries (Viralzone: Alphapapillomavirus)
| Evidence for the existence of protein | Percentage of entries |
|---|---|
| at protein level | N/A |
| at transcript level | N/A |
| inferred from homology | 100% |
| predicted | N/A |
| uncertain | N/A |
| Annotation categories | Entries with | Number of annotations | Coverage |
|---|---|---|---|
| PubMed citations | 6 | 0 unique | 100% |
| Alternative products | 0 | 0 | N/A |
| General annotation | 6 | 25 | 100% |
| Function | 6 | 6 | 100% |
| Catalytic activity | 1 | 1 | 16.7% |
| Subcellular location | 5 | 25 | 83.3% |
| Subunit / Interacts with host | 4 | - | 66.7% |
| Sequence annotation | 4 | 9 | 66.7% |
| Amino acid modifications | 1 | 1 | 16.7% |
| Mutagenesis | 0 | 0 | N/A |
| Cross-references | 6 | 71 | 100% |
| EMBL | 6 | 7 | 100% |
| InterPro | 6 | 14 | 100% |
| PDB | 0 | 0 | N/A |
| RefSeq | 6 | 6 | 100% |
100% of reviewed HPV32 entries are annotated with at least one keyword.
100% of reviewed HPV32 entries are annotated with at least one GO (Gene Ontology) term.
Human SARS coronavirus (SARS-CoV)
15 entries (Viralzone: Betacoronavirus)
| Evidence for the existence of protein | Percentage of entries |
|---|---|
| at protein level | 60% |
| at transcript level | N/A |
| inferred from homology | 6.7% |
| predicted | 33.3% |
| uncertain | N/A |
| Annotation categories | Entries with | Number of annotations | Coverage |
|---|---|---|---|
| PubMed citations | 15 | 76 unique | 100% |
| Alternative products | 2 | 4 | 13.3% |
| General annotation | 13 | 148 | 86.7% |
| Function | 11 | 22 | 73.3% |
| Catalytic activity | 2 | 6 | 13.3% |
| Subcellular location | 13 | 148 | 86.7% |
| Subunit / Interacts with host | 6 | - | 40% |
| Sequence annotation | 14 | 836 | 93.3% |
| Amino acid modifications | 4 | 33 | 26.7% |
| Mutagenesis | 3 | 26 | 20% |
| Cross-references | 15 | 976 | 100% |
| EMBL | 15 | 369 | 100% |
| InterPro | 14 | 48 | 93.3% |
| PDB | 7 | 219 | 46.7% |
| RefSeq | 12 | 12 | 80% |
100% of reviewed SARS entries are annotated with at least one keyword.
86.7% of reviewed SARS entries are annotated with at least one GO (Gene Ontology) term.
Variola virus (isolate Human/India/Ind3/1967) (VARV)
159 entries (Viralzone: Orthopoxvirus)
| Evidence for the existence of protein | Percentage of entries |
|---|---|
| at protein level | 2.5% |
| at transcript level | 28.9% |
| inferred from homology | 66% |
| predicted | 2.5% |
| uncertain | N/A |
| Annotation categories | Entries with | Number of annotations | Coverage |
|---|---|---|---|
| PubMed citations | 159 | 22 unique | 100% |
| Alternative products | 0 | 0 | N/A |
| General annotation | 159 | 695 | 100% |
| Function | 124 | 126 | 78% |
| Catalytic activity | 27 | 31 | 17% |
| Subcellular location | 98 | 695 | 61.6% |
| Subunit / Interacts with host | 20 | - | 12.6% |
| Sequence annotation | 101 | 514 | 63.5% |
| Amino acid modifications | 27 | 76 | 17% |
| Mutagenesis | 1 | 1 | 0.6% |
| Cross-references | 159 | 2,102 | 100% |
| EMBL | 159 | 464 | 100% |
| InterPro | 155 | 299 | 97.5% |
| PDB | 2 | 4 | 1.3% |
| RefSeq | 157 | 157 | 98.7% |
100% of reviewed Variola virus entries are annotated with at least one keyword.
79.9% of reviewed Variola virus entries are annotated with at least one GO (Gene Ontology) term.